Breakout Sessions

Breakout session timing and panelists coming soon.


The Price is Right? U.S. Pharmaceutical Pricing Transparency and Sustainability

High and increasing price tags on brand medications in the U.S. pharmaceutical market have made headlines and drawn public ire in recent years – but how high is too high? What is the standard of care to which we are comparing these advancements and their prices? This session will focus on the nuances of product pricing for biologics, biosimilars and orphan drugs compared to small-molecule pharmaceuticals, and will address how the landscape of federal policy and varied stakeholders’ incentives in the U.S. life sciences industry have impacted the prices patients and payers face. The session will bring together perspectives from academia, the private and public sectors to discuss how U.S. policy and industry innovation have led to modern prices and what the future of pharmaceutical product pricing holds.


The Changing Landscape of Venture Capital in Healthcare: Innovating and Financing Next Gen Solutions

Over the past decade, healthcare entrepreneurship has boomed with innovators developing solutions that aim to fix the challenges and complexities of the U.S. healthcare system. As the quantity and size of healthcare start-ups on the market continue to rise, investors have financed these solutions through venture capital. This session will explore the growing and changing role of venture capital in healthcare and how investors have helped to bring next generation, high-impact solutions to market. Biotechnology firms have historically commanded the highest VC investments of all healthcare sectors, and investors have played a critical role in expanding and improving access to medications and devices for rare or undertreated conditions accordingly. Population health, digital health and delivery-oriented enterprises have also attracted more funds in recent years. The session will include voices from healthcare investors, entrepreneurs and accelerator leadership.


Frontiers of Healthcare Technology: The Role of Telemedicine and Patient-Centered Innovation 

As the healthcare industry continues to innovate to expand and improve care, technological solutions have become increasingly important. This session will focus on advancements such as telemedicine, remote patient monitoring, and other critical technologies emerging that are aimed at improving patient health experience. Panelists will discuss the advances these technologies have made and barriers for future adoption. The Healthcare Technology panel will bring together speakers from organizations that have designed and implemented telemedicine and RPM programs, or have utilized technology in personalized medicine to drive innovation, enhance healthcare quality or improve access.


When Access Should be Limited: Combating Waste and Overutilization in US Healthcare

With the Choosing Wisely® initiative and others like it, there is a newfound focus on preventing wasteful or unnecessary treatment in healthcare. This session will explore various ways in which delivery providers and insurers are countering overutilization and promoting high value care. How should we educate patients and providers on this topic and change prevailing views that “more is always better”? Which solutions are most successful for limiting unnecessary services? 


Healthcare Policy and the Employee: The Future of Employer-Sponsored Healthcare Coverage

Employer-sponsored health insurance has remained an integral component of the U.S. healthcare system for more than fifty years. As political tensions continue over the appropriate means for providing healthcare coverage in the U.S., understanding the unique and important role of employers is critical. This session will focus on employer-sponsored healthcare coverage, discussing its history, recent changes, and necessary policy solutions for the future. It will be relevant for employers, employees, and those innovating coverage outside of employer-sponsored care.


The Role of Partnerships in Improving Population Health: Who Should Partner, for What and How? 

With the shift towards population health well underway, there is increasing focus on integrating services beyond the four walls of the hospital to improve the health of communities overall. This movement has not only included new roles for non-profit organizations (e.g., legal aid), but also for a wide range of private partners. This session will explore a range of innovative partnerships aimed at achieving the Triple Aim. How are these partnerships structured and financed? What leads to their success; and, equally important, what hinders them?


Beyond the Hospital:  The Role of Retail Clinics, Free Clinics and Urgent Care as Alternative Sites of Care

Health care continues to be a complex structure but, despite efforts to improve services, access remains an elusive option for many consumers.  As appointment wait times continue to increase, patient panels fill up, and major medical centers remain inaccessible to undocumented communities the search for medical care that is quick, accessible, and efficient intensifies.  In this panel, we discuss the role that retail clinics, free clinics, and urgent care play in changing the health care landscape.  Are they cost effective?  Do they provide rapid response without sacrificing safety and efficiency? Can they provide positive health outcomes and encourage earlier disease management?


Aging Populations in Healthcare:  The Impact of Long Term Care and Home Health Access on Health Expenditures and Patient Outcomes

Former Vice President Hubert Humphrey once said, “The moral test of government is how that government treats those who are in the dawn of life, the children; those who are in the twilight of life, the elderly; and those who are in the shadows of life, the sick, the needy, and the handicapped."  As healthcare consumes a larger portion of annual GDP and life expectancy increases produce an older population former Vice President Humphrey’s words carry heavier meaning.  In this panel, we discuss the unique potential for long term care and home health access to manage chronic health conditions and the complex health needs of aging populations without exacerbating health expenditures. 


Battling Inequity:  The Role of Community Stakeholders in Addressing Social Determinants of Health Across the Care Continuum

Despite continuous breakthroughs in medical research and advances in developing novel pharmaceutical agents, there continues to be rampant health inequity.  Chronic and acute conditions alike continuously plague communities along socio-demographic axes including race, gender, and socioeconomic status.   As health care shifts toward a preventative care lens the question on everyone’s minds remains – how do we stop health inequity and who can play a role?  In this panel, we discuss the role of local community members (i.e. stakeholders) in ameliorating health inequity before, during, and after acute medical care.  We will explore not just the potential for local mobilization but how to maintain and enhance these movements. 


The Case for Vertical Integration: Do Replicable Models Exist?

Vertical integration between payors and providers is increasing and evolving, taking shape in models that span the range from full to partial allocation of risk. Large, integrated health systems have existed for decades in a few markets and some have demonstrated the ability to provide high quality services while controlling costs. More recently, accountable care organizations have formed to internalize financial risk within a provider network while seeking to maintain quality. Novel partnerships between insurers and health systems are also emerging, offering alternatives to full integration that nonetheless attempt to align incentives and reallocate risk. Can vertical integration keep costs down and quality up? Which models work, and how can they be scaled? After a brief overview of trends in value-based care and integration, panelists will detail their organization’s approach to integration, results, and potential replicability. The implications of vertical payor-provider integration for broader health system reform will be examined.